Filing Details
- Accession Number:
- 0001209191-22-043379
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-28 16:04:52
- Reporting Period:
- 2022-07-26
- Accepted Time:
- 2022-07-28 16:04:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124140 | Exact Sciences Corp | EXAS | Services-Medical Laboratories (8071) | 204782291 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1367313 | S Katherine Zanotti | C/O Exact Sciences Corp. 5505 Endeavor Lane Madison WI 53719 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-07-26 | 4,608 | $10.18 | 64,926 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-07-26 | 4,608 | $45.14 | 60,318 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-07-26 | 4,608 | $0.00 | 4,608 | $10.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-07-26 | 2022-07-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,739 | Indirect | By grantor retained annuity trust |
Footnotes
- Represents shares of common stock received upon exercise of a stock option award.
- The exercise reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into in November 2021.
- The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into in November 2021.
Billionaire Hedge Funds
